Financials Ocugen, Inc.

Equities

OCGN

US67577C1053

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 01:36:20 10/02/2026 am IST			5-day change	1st Jan Change
1.395 ^USD	+4.89%		-2.79%	+2.97%

06:14pm	Ocugen Names Rita Johnson-Greene as CFO	MT
05:49pm	Ocugen appoints Rita Johnson-Greene to chief financial officer	RE

Projected Income Statement: Ocugen, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	0.0426	-	-	6.036	4.055	5.402	3.08	159.5
Change	-	-	-	-	-32.82%	33.23%	-42.99%	5,078.51%
EBITDA	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
EBIT ¹	-21.28	-58.03	-84.87	-65.53	-54.76	-64.37	-77.16	-11.52
Change	-	-172.63%	-46.25%	22.78%	16.44%	-17.55%	-19.88%	85.07%
Interest Paid	-0.721	-0.079	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-58.42	-81.35	-63.08	-54.05	-70.46	-89.48	-13.36
Change	-	-	-39.26%	22.46%	14.31%	-30.36%	-26.99%	85.07%
Net income ¹	-	-58.36	-81.35	-63.08	-54.05	-69.29	-79.72	-13.36
Change	-	-	-39.38%	22.46%	14.31%	-28.18%	-15.05%	83.24%
Announcement Date	18/03/21	25/02/22	28/02/23	16/04/24	05/03/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	-	-	-	-	-	-	-	-	-	-	-	1.419	1.014	1.141	1.136	0.764	1.481	1.373	1.752	0.86	0.5	0.55	0.6	0.7
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-28.54%	12.52%	-0.44%	-32.75%	93.85%	-7.29%	27.6%	-50.91%	-41.86%	10%	9.09%	16.67%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-3.807	-7.057	-25.61	-10.79	-14.57	-18.03	-19.56	-23.12	-24.15	-17.75	-23.73	-15.42	-11.52	-	-15.45	-13.25	-13.84	-14.5	-13.8	-17.62	-18.45	-15.89	-15.76	-16.49	-16.86
Change	-	-85.35%	-262.9%	57.87%	-35.06%	-23.76%	-8.49%	-18.17%	-4.46%	26.5%	-33.7%	35.01%	25.28%	-	-	14.22%	-4.44%	-4.78%	4.87%	-27.76%	-4.66%	13.87%	0.82%	-4.68%	-2.24%
Charge d'intérêts	-0.1662	-0.02	-0.02	-0.019	-0.02	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-7.077	-25.95	-10.81	-14.58	-18.02	-19.47	-21.92	-21.94	-16.5	-22.92	-14.16	-10.97	-	-15.28	-12.97	-13.88	-15.35	-14.74	-20.05	-20.32	-17.89	-18.63	-20.11	-20.85
Change	-	-	-266.71%	58.36%	-34.92%	-23.58%	-8.06%	-12.59%	-0.08%	24.8%	-38.96%	38.22%	22.55%	-	-	15.12%	-7.02%	-10.59%	3.98%	-36.04%	-1.35%	11.95%	-4.12%	-7.92%	-3.68%
Net income ¹	-	-7.077	-25.95	-10.76	-14.58	-18.02	-19.47	-21.92	-21.94	-16.5	-22.92	-14.16	-10.97	-	-15.28	-12.97	-13.88	-15.35	-14.74	-20.05	-19.15	-16.85	-16.72	-17.45	-17.82
Change	-	-	-266.71%	58.56%	-35.57%	-23.58%	-8.06%	-12.59%	-0.08%	24.8%	-38.96%	38.22%	22.55%	-	-	15.12%	-7.02%	-10.59%	3.98%	-36.04%	4.5%	12.02%	0.78%	-4.42%	-2.12%
Announcement Date	18/03/21	07/05/21	06/08/21	09/11/21	25/02/22	06/05/22	05/08/22	08/11/22	28/02/23	05/05/23	21/08/23	09/11/23	16/04/24	14/05/24	08/08/24	08/11/24	05/03/25	09/05/25	01/08/25	05/11/25	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Ocugen, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	18/03/21	25/02/22	28/02/23	16/04/24	05/03/25	-	-	-

Estimates

Cash Flow Forecast: Ocugen, Inc.

Fiscal Period: December	2020	2022	2024	2025	2026	2027
CAPEX ¹	0.3068	4.457	3.385	-	-	-
Change	-	-	-	-100%	-	-
Free Cash Flow (FCF) ¹	-15.02	-	-45.53	-60.75	-59.2	38.45
Change	-	-	-	-33.44%	2.55%	164.95%
Announcement Date	18/03/21	28/02/23	05/03/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Ocugen, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-	-
EBIT Margin (%)	-	-49,940.69%	-	-	-1,085.67%	-1,350.36%	-1,191.45%	-2,505.19%	-7.22%
EBT Margin (%)	-	-	-	-	-1,045.03%	-1,333.02%	-1,304.28%	-2,905.11%	-8.38%
Net margin (%)	-	-	-	-	-1,045.03%	-1,333.02%	-1,282.55%	-2,588.26%	-8.38%
FCF margin (%)	-	-35,231.25%	-	-	-	-1,122.74%	-1,124.5%	-1,922.08%	24.11%
FCF / Net Income (%)	-	-	-	-	-	84.23%	87.68%	74.26%	-287.79%
Profitability
ROA	-91.91%	-37.3%	-54.48%	-49.48%	-47.3%	-46.57%	-	-	-
ROE	2,393.98%	-134%	-99.46%	-90.46%	-110.14%	-154.01%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	719.92%	-	-	-	83.48%	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-2.04%	-	-	-	-7.44%	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-0.31	-0.3	-0.38	-0.26	-0.2	-0.228	-0.236	-0.035
Change	-	-	3.23%	-26.67%	31.58%	23.08%	-14%	-3.51%	85.17%
Nbr of stocks (in thousands)	-	1,62,026	1,99,186	2,18,887	2,56,502	2,91,320	3,27,888	3,27,888	3,27,888
Announcement Date	-	18/03/21	25/02/22	28/02/23	16/04/24	05/03/25	-	-	-